Campedel, L.; Blanc-Durand, P.; Bin Asker, A.; Lehmann-Che, J.; Cuvier, C.; De Bazelaire, C.; Teixeira, L.; Becourt, S.; Ledoux, F.; Hocini, H.;
et al. Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC. Cancers 2020, 12, 2657.
https://doi.org/10.3390/cancers12092657
AMA Style
Campedel L, Blanc-Durand P, Bin Asker A, Lehmann-Che J, Cuvier C, De Bazelaire C, Teixeira L, Becourt S, Ledoux F, Hocini H,
et al. Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC. Cancers. 2020; 12(9):2657.
https://doi.org/10.3390/cancers12092657
Chicago/Turabian Style
Campedel, Luca, Paul Blanc-Durand, Asker Bin Asker, Jacqueline Lehmann-Che, Caroline Cuvier, Cedric De Bazelaire, Luis Teixeira, Stephanie Becourt, Florence Ledoux, Hamid Hocini,
and et al. 2020. "Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC" Cancers 12, no. 9: 2657.
https://doi.org/10.3390/cancers12092657
APA Style
Campedel, L., Blanc-Durand, P., Bin Asker, A., Lehmann-Che, J., Cuvier, C., De Bazelaire, C., Teixeira, L., Becourt, S., Ledoux, F., Hocini, H., Bourstyn, E., Miquel, C., Guillerm, S., Charveriat, P., Espié, M., De Roquancourt, A., Hamy, A. -S., & Giacchetti, S.
(2020). Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC. Cancers, 12(9), 2657.
https://doi.org/10.3390/cancers12092657
